ArticleVaccine2025

Human papillomavirus type 16 and 18 viral clearance and progression to precancer among women aged 18-25 years enrolled in the Costa Rica HPV prophylactic vaccine trial (CVT).

Mónica S Sierra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.